Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.50M | -13.72M | -17.52M | -12.89M | -8.67M |
| Total Depreciation and Amortization | 33.00K | 38.00K | 30.00K | 29.00K | 38.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.08M | 1.38M | 584.00K | 3.51M | 491.00K |
| Change in Net Operating Assets | 1.84M | -2.07M | 1.27M | -2.79M | -3.01M |
| Cash from Operations | -10.55M | -14.38M | -15.64M | -12.14M | -11.15M |
| Capital Expenditure | -260.00K | -- | 0.00 | -109.00K | -77.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.00M | -12.96M | 25.54M | 15.37M | 4.86M |
| Cash from Investing | -57.26M | -12.96M | 25.54M | 15.26M | 4.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103.70M | 5.00K | 65.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -86.00K | -- | -- |
| Cash from Financing | 103.70M | 5.00K | -21.00K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.89M | -27.33M | 9.88M | 3.12M | -6.34M |